Lapera, Hanna Jane P.

HRN: 29-39-63  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2026
CEFUROXIME 750MG (VIAL)
07/31/2026
08/07/2026
IV
350mg
Q 8
PCAP
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines